Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Intracerebral metastases of malignant melanoma and their recurrences--a clinical analysis.

Miller D, Zappala V, El Hindy N, Livingstone E, Schadendorf D, Sure U, Sandalcioglu IE.

Clin Neurol Neurosurg. 2013 Sep;115(9):1721-8. doi: 10.1016/j.clineuro.2013.03.019. Epub 2013 May 1.

PMID:
23643143
[PubMed - indexed for MEDLINE]
2.

Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.

Caballero JA, Sneed PK, Lamborn KR, Ma L, Denduluri S, Nakamura JL, Barani IJ, McDermott MW.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):303-9. doi: 10.1016/j.ijrobp.2011.06.1987. Epub 2011 Nov 11.

PMID:
22079723
[PubMed - indexed for MEDLINE]
3.

Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article.

Liew DN, Kano H, Kondziolka D, Mathieu D, Niranjan A, Flickinger JC, Kirkwood JM, Tarhini A, Moschos S, Lunsford LD.

J Neurosurg. 2011 Mar;114(3):769-79. doi: 10.3171/2010.5.JNS1014. Epub 2010 Jun 4.

PMID:
20524829
[PubMed - indexed for MEDLINE]
4.

Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease.

Pollock BE, Brown PD, Foote RL, Stafford SL, Schomberg PJ.

J Neurooncol. 2003 Jan;61(1):73-80. Review.

PMID:
12587798
[PubMed - indexed for MEDLINE]
5.

Hemangiopericytoma: long-term outcome revisited. Clinical article.

Schiariti M, Goetz P, El-Maghraby H, Tailor J, Kitchen N.

J Neurosurg. 2011 Mar;114(3):747-55. doi: 10.3171/2010.6.JNS091660. Epub 2010 Jul 30.

PMID:
20672899
[PubMed - indexed for MEDLINE]
6.

Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.

Selek U, Chang EL, Hassenbusch SJ 3rd, Shiu AS, Lang FF, Allen P, Weinberg J, Sawaya R, Maor MH.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1097-106.

PMID:
15234044
[PubMed - indexed for MEDLINE]
7.

Analysis of prognostic factors for patients with single brain metastasis treated with stereotactic radiosurgery.

Fernandez-Vicioso E, Suh JH, Kupelian PA, Sohn JW, Barnett GH.

Radiat Oncol Investig. 1997;5(1):31-7.

PMID:
9303054
[PubMed - indexed for MEDLINE]
8.

Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy?

Hasegawa T, Kondziolka D, Flickinger JC, Germanwala A, Lunsford LD.

Neurosurgery. 2003 Jun;52(6):1318-26; discussion 1326.

PMID:
12762877
[PubMed - indexed for MEDLINE]
9.

Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival.

Mori Y, Kondziolka D, Flickinger JC, Kirkwood JM, Agarwala S, Lunsford LD.

Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):581-9.

PMID:
9806518
[PubMed - indexed for MEDLINE]
10.

Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival.

Knisely JP, Yu JB, Flanigan J, Sznol M, Kluger HM, Chiang VL.

J Neurosurg. 2012 Aug;117(2):227-33. doi: 10.3171/2012.5.JNS111929. Epub 2012 Jun 15.

PMID:
22702482
[PubMed - indexed for MEDLINE]
11.

Factors affecting the outcome after treatment for metastatic melanoma to the brain.

Carrubba CJ, Vitaz TW.

Surg Neurol. 2009 Dec;72(6):707-11. doi: 10.1016/j.surneu.2009.03.005. Epub 2009 Jul 14.

PMID:
19604550
[PubMed - indexed for MEDLINE]
12.

Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery.

Yu C, Chen JC, Apuzzo ML, O'Day S, Giannotta SL, Weber JS, Petrovich Z.

Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1277-87.

PMID:
11955740
[PubMed - indexed for MEDLINE]
13.

Gamma knife radiosurgery in the management of malignant melanoma brain metastases.

Mathieu D, Kondziolka D, Cooper PB, Flickinger JC, Niranjan A, Agarwala S, Kirkwood J, Lunsford LD.

Neurosurgery. 2007 Mar;60(3):471-81; discussion 481-2.

PMID:
17327791
[PubMed - indexed for MEDLINE]
14.

Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.

Grandhi R, Kondziolka D, Panczykowski D, Monaco EA 3rd, Kano H, Niranjan A, Flickinger JC, Lunsford LD.

J Neurosurg. 2012 Aug;117(2):237-45. doi: 10.3171/2012.4.JNS11870. Epub 2012 May 25.

PMID:
22631694
[PubMed - indexed for MEDLINE]
15.

Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications.

Lavine SD, Petrovich Z, Cohen-Gadol AA, Masri LS, Morton DL, O'Day SJ, Essner R, Zelman V, Yu C, Luxton G, Apuzzo ML.

Neurosurgery. 1999 Jan;44(1):59-64; discussion 64-6.

PMID:
9894964
[PubMed - indexed for MEDLINE]
16.

Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma.

Powell JW, Chung CT, Shah HR, Canute GW, Hodge CJ, Bassano DA, Liu L, Mitchell L, Hahn SS.

J Neurosurg. 2008 Dec;109 Suppl:122-8. doi: 10.3171/JNS/2008/109/12/S19.

PMID:
19123898
[PubMed - indexed for MEDLINE]
17.

Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.

Karlovits BJ, Quigley MR, Karlovits SM, Miller L, Johnson M, Gayou O, Fuhrer R.

Neurosurg Focus. 2009 Dec;27(6):E7. doi: 10.3171/2009.9.FOCUS09191.

PMID:
19951060
[PubMed - indexed for MEDLINE]
18.

Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors.

Koc M, McGregor J, Grecula J, Bauer CJ, Gupta N, Gahbauer RA.

J Neurooncol. 2005 Feb;71(3):307-13.

PMID:
15735922
[PubMed - indexed for MEDLINE]
19.

Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.

Golden DW, Lamborn KR, McDermott MW, Kunwar S, Wara WM, Nakamura JL, Sneed PK.

J Neurosurg. 2008 Dec;109 Suppl:77-86. doi: 10.3171/JNS/2008/109/12/S13.

PMID:
19123892
[PubMed - indexed for MEDLINE]
20.

Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.

Seegenschmiedt MH, Keilholz L, Altendorf-Hofmann A, Urban A, Schell H, Hohenberger W, Sauer R.

Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):607-18.

PMID:
10348291
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk